Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
46.67
-0.75 (-1.58%)
At close: Dec 5, 2025, 4:00 PM EST
46.60
-0.07 (-0.15%)
After-hours: Dec 5, 2025, 5:48 PM EST
Crinetics Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 4,429 | 4,742 | 2,377 | 985 | 1,340 | 465 | |
| Market Cap Growth | -13.44% | 99.50% | 141.36% | -26.50% | 188.40% | -23.56% | |
| Enterprise Value | 3,385 | 3,932 | 1,874 | 620 | 1,151 | 283 | |
| Last Close Price | 46.67 | 51.13 | 35.58 | 18.30 | 28.41 | 14.11 | |
| PS Ratio | 2885.08 | 4563.69 | 592.26 | 207.88 | 1242.80 | 6542.73 | |
| PB Ratio | 4.12 | 3.58 | 4.41 | 3.11 | 4.04 | 2.75 | |
| P/TBV Ratio | 4.13 | 3.58 | 4.41 | 3.11 | 4.04 | 2.75 | |
| EV/Sales Ratio | 2205.51 | 3783.97 | 467.04 | 130.82 | 1067.39 | 3982.45 | |
| Debt / Equity Ratio | 0.05 | 0.04 | 0.10 | 0.01 | 0.01 | 0.03 | |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0 | |
| Quick Ratio | 14.73 | 22.83 | 12.92 | 12.17 | 20.96 | 16.47 | |
| Current Ratio | 15.12 | 23.05 | 13.07 | 12.45 | 21.55 | 16.92 | |
| Return on Equity (ROE) | -44.42% | -32.02% | -50.16% | -50.57% | -42.98% | -51.61% | |
| Return on Assets (ROA) | -28.00% | -20.46% | -28.18% | -29.84% | -25.19% | -29.85% | |
| Return on Capital (ROIC) | -29.76% | -21.53% | -30.57% | -32.02% | -26.41% | -31.60% | |
| Return on Capital Employed (ROCE) | -42.60% | -24.60% | -37.60% | -51.70% | -32.10% | -43.30% | |
| Earnings Yield | -9.55% | -6.29% | -9.03% | -16.65% | -8.04% | -15.89% | |
| FCF Yield | -7.99% | -4.85% | -7.20% | -11.87% | -6.64% | -13.39% | |
| Buyback Yield / Dilution | -24.75% | -39.11% | -11.71% | -35.24% | -26.24% | -25.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.